James Hippel
2020
In 2020, James Hippel earned a total compensation of $3.2M as Executive Vice President and CFO at Bio-Techne, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $576,716 |
|---|---|
| Option Awards | $1,502,483 |
| Salary | $566,000 |
| Stock Awards | $502,389 |
| Other | $9,470 |
| Total | $3,157,058 |
Hippel received $1.5M in option awards, accounting for 48% of the total pay in 2020.
Hippel also received $576.7K in non-equity incentive plan, $566K in salary, $502.4K in stock awards and $9.5K in other compensation.
Rankings
In 2020, James Hippel's compensation ranked 3,684th out of 13,090 executives tracked by ExecPay. In other words, Hippel earned more than 71.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,684 out of 13,090 | 72nd |
Division Manufacturing | 1,448 out of 5,617 | 74th |
Major group Chemicals And Allied Products | 546 out of 2,248 | 76th |
Industry group Drugs | 473 out of 1,948 | 76th |
Industry Biological Products, Except Diagnostic Substances | 113 out of 411 | 73rd |
Source: SEC filing on September 14, 2022.
Hippel's colleagues
We found four more compensation records of executives who worked with James Hippel at Bio-Techne in 2020.